The Trump Administration is poised to make a settlement with Purdue Pharma that it can claim as a victory for opioid victims. But the proposed outcome would leave the company’s owners enormously wealthy—and off the hook for good.
Trending:
Purdue Pharma and the Sackler family's plan to keep its billions